1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Rheumatology Arthritis Therapeutics Market
2.2. Global Rheumatology Arthritis Therapeutics Market, By Disease Type, 2023 (US$ Million)
2.3. Global Rheumatology Arthritis Therapeutics Market, By Drug Type, 2023 (US$ Million)
2.4. Global Rheumatology Arthritis Therapeutics Market, By Method of Administration, 2023 (US$ Million)
2.5. Global Rheumatology Arthritis Therapeutics Market, By Mode of Sale, 2023 (US$ Million)
2.6. Global Rheumatology Arthritis Therapeutics Market, By End User, 2023 (US$ Million)
2.7. Global Rheumatology Arthritis Therapeutics Market, By Geography, 2023 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2023

3. Rheumatology Arthritis Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Rheumatology Arthritis Therapeutics Market Vendors
3.2. Strategies Adopted by Rheumatology Arthritis Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Rheumatology Arthritis Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Rheumatology Arthritis Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Osteoarthritis
5.3.2. Ankylosing spondylitis
5.3.3. Rheumatoid arthritis
5.3.4. Gout
5.3.5. Psoriatic arthritis
5.3.6. Reactive arthritis
5.3.7. Fibromyalgia
5.3.8. Scleroderma
5.3.9. Others

6. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Pharmaceuticals
6.3.1.1. NSAIDs
6.3.1.2. Analgesics
6.3.1.3. DMARDs
6.3.1.4. Glucocorticoids
6.3.2. Biopharmaceuticals
6.3.2.1. Biologics
6.3.2.2. TNF-α antagonists
6.3.2.3. T-cell inhibitors
6.3.2.4. CD20 antigen
6.3.2.5. JAK inhibitors
6.3.2.6. anti-IL6 biologics
6.3.3. Biosimilars
6.3.3.1. CD20 antigen
6.3.3.2. TNF-α antagonists

7. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Topical
7.3.2. Oral
7.3.3. Parenteral

8. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Prescription drugs
8.3.2. Over-the-counter drugs

9. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2023 Versus 2032
9.3. Market Segmentation
9.3.1. Hospitals
9.3.2. Medical clinics
9.3.3. Online channel
9.3.4. Retail Channel


10. North America Rheumatology Arthritis Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
10.3. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
10.4. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
10.5. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
10.6. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
10.7.Rheumatology Arthritis Therapeutics Market: By Region, 2022-2032, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
10.7.1.1.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
10.7.1.1.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
10.7.1.1.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
10.7.1.1.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
10.7.1.2.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
10.7.1.2.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
10.7.1.2.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
10.7.1.2.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
10.7.1.3.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
10.7.1.3.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
10.7.1.3.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
10.7.1.3.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)

11. UK and European Union Rheumatology Arthritis Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.3. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.4. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.5. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.6. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.Rheumatology Arthritis Therapeutics Market: By Region, 2022-2032, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.1.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.1.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.1.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.1.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.2.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.2.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.2.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.2.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.3.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.3.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.3.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.3.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.4.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.4.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.4.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.4.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.1.5. France
11.7.1.5.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.5.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.5.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.5.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.5.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
11.7.1.6.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
11.7.1.6.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
11.7.1.6.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
11.7.1.6.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)

12. Asia Pacific Rheumatology Arthritis Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.3. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.4. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.5. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.6. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.Rheumatology Arthritis Therapeutics Market: By Region, 2022-2032, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.1.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.1.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.1.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.1.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.2.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.2.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.2.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.2.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.1.3. India
12.7.1.3.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.3.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.3.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.3.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.3.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.4.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.4.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.4.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.4.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.5.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.5.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.5.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.5.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
12.7.1.6.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
12.7.1.6.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
12.7.1.6.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
12.7.1.6.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)

13. Latin America Rheumatology Arthritis Therapeutics Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
13.3. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
13.4. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
13.5. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
13.6. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
13.7.Rheumatology Arthritis Therapeutics Market: By Region, 2022-2032, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
13.7.1.1.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
13.7.1.1.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
13.7.1.1.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
13.7.1.1.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
13.7.1.2.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
13.7.1.2.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
13.7.1.2.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
13.7.1.2.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
13.7.1.3.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
13.7.1.3.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
13.7.1.3.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
13.7.1.3.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)

14. Middle East and Africa Rheumatology Arthritis Therapeutics Market, 2022-2032, USD (Million)
14.1. Market Overview
14.2. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
14.3. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
14.4. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
14.5. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
14.6. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
14.7.Rheumatology Arthritis Therapeutics Market: By Region, 2022-2032, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
14.7.1.1.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
14.7.1.1.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
14.7.1.1.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
14.7.1.1.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
14.7.1.2.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
14.7.1.2.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
14.7.1.2.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
14.7.1.2.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Rheumatology Arthritis Therapeutics Market: By Disease Type, 2022-2032, USD (Million)
14.7.1.3.2. Rheumatology Arthritis Therapeutics Market: By Drug Type, 2022-2032, USD (Million)
14.7.1.3.3. Rheumatology Arthritis Therapeutics Market: By Method of Administration, 2022-2032, USD (Million)
14.7.1.3.4. Rheumatology Arthritis Therapeutics Market: By Mode of Sale, 2022-2032, USD (Million)
14.7.1.3.5. Rheumatology Arthritis Therapeutics Market: By End User, 2022-2032, USD (Million)

15. Company Profile
15.1. AbbVie
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Boehringer Ingelheim GmbH
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Novartis AG
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Regeneron Pharmaceuticals, Inc.
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Pfizer, Inc.
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Bristol-Myers Squibb Company
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. F. Hoffmann-La Roche Ltd.
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. UCB S.A.
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Johnson & Johnson Services, Inc.
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Amgen, Inc.
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Other Notable Players
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives